Bausch + Lomb rises as Brent Saunders returns as CEO

Bausch Health Companies

15/02/2023 13:12

** U.S.-listed shares of Bausch + Lomb Corp  BLCO.N  gain
6.5% to $18.09 premarket 
    ** Eye-care company names Brent Saunders, former chief
executive officer of Botox maker Allergan, as its CEO  
    ** Saunders to take over the top role from Joseph Papa on
March 6
    ** The appointment marks Saunders' return to BLCO after
nearly a decade  
    ** He previously headed Bausch + Lomb until its acquisition
in 2013 by Bausch Health Companies, which was then known as
Valeant Pharmaceuticals
    ** U.S.-listed BLCO shares up ~13% in the past three months 
 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))